What Happened

Smith Family Pharmacy in Barbourville, Kentucky, and its pharmacist-in-charge, Stephanie Smith, agreed to pay $215,000 in civil penalties after the government alleged the pharmacy repeatedly filled controlled-substance prescriptions bearing unresolved diversion red flags.

From April 2017 to December 2021, Smith Family Pharmacy filled more than 500 prescriptions for oxycodone and oxymorphone — highly addictive Schedule II drugs — that displayed recognized red flags for diversion or abuse: combinations of commonly abused substances, unusually high dosages, and patients traveling from out of state to see the prescribing physician. Under the Controlled Substances Act's corresponding-responsibility rule, a pharmacy must investigate and resolve such red flags before dispensing, or refuse to fill the prescription.

Some of the flagged prescriptions had been written by out-of-state physicians who were later convicted of illegally prescribing controlled substances in a separate federal case. The government's investigation found the pharmacy filled the prescriptions anyway without documenting how any red flags had been resolved.

What Went Wrong

  • Red flags were not investigated before dispensing. Prescriptions showing multiple recognized diversion indicators were filled without any documented resolution of the concerns.
  • Out-of-state prescribing wasn't treated as a standalone red flag. Patients traveling long distances to obtain Schedule II prescriptions should have prompted extra scrutiny rather than routine fills.
  • The pattern persisted for more than four years. Over 500 flagged prescriptions were filled before the DEA's investigation intervened, indicating no internal review process caught the trend.

How It Could Have Been Prevented

  • Document the specific steps taken to resolve each red flag identified on a controlled-substance prescription before dispensing, not just that a flag was noticed.
  • Treat long-distance travel to a prescriber, combined with high-risk drug combinations or dosages, as a mandatory hold for pharmacist review.
  • Run periodic internal audits of prescriber patterns across the pharmacy's own fill history to catch a rising volume of red-flag prescriptions from the same source.
  • Train pharmacists on the CSA's corresponding-responsibility standard and maintain a documented refusal-to-fill process for unresolved red flags.

Related Guidance

Sources